Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Syncope With Sympathoadrenal Imbalance
NCT00060866Phase 4Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propranolol in Neurocardiogenic syncope (NCS) (2 arms), sponsored by National Institute of Neurological Disorders and Stroke. Primary endpoint: Occurrence of tilt-induced Neurocardiogenic Syncope. Started May 2003; status: completed.
02
Drugs
propranolol
03
Conditions
Neurocardiogenic syncope (NCS)
Beyond the preview
Go deeper on NCT00060866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060866.